[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Alcohol Addiction Therapeutics In-Depth Research Report 2017-2022

December 2017 | 110 pages | ID: GEFC7A4C8E2EN
US Market Insights (UMI)

US$ 3,190.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Alcohol Addiction Therapeutics industry.

Major Companies

AstraZeneca Plc
BioCorRx Inc
Bionex Pharmaceuticals LLC
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Montisera Ltd
Omeros Corp
Opiant Pharmaceuticals Inc

Key Regions

North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main types of products

Alcohol Addiction Therapeutics Market, by-1212
Alcohol Addiction Therapeutics Market, byDP-002
Alcohol Addiction Therapeutics Market, by705253
Alcohol Addiction Therapeutics Market, byT-436
Alcohol Addiction Therapeutics Market, byX-71441

Alcohol Addiction Therapeutics Market, by Key Consumers

Hospital
Clinic
Others

CHAPTER ONE GLOBAL ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW

1.1 Global Alcohol Addiction Therapeutics Market Sales Volume Revenue and Price 2012-2017
1.2 Alcohol Addiction Therapeutics, by 1212 2012-2017
  1.2.1 Global Alcohol Addiction Therapeutics Sales Market Share by 1212 2012-2017
  1.2.2 Global Alcohol Addiction Therapeutics Revenue Market Share by 1212 2012-2017
  1.2.3 Global Alcohol Addiction Therapeutics Price by 1212 2012-2017
  1.2.4
  1.2.5
1.3 Alcohol Addiction Therapeutics, by P-002 2012-2017
  1.3.1 Global Alcohol Addiction Therapeutics Sales Market Share by P-002 2012-2017
  1.3.2 Global Alcohol Addiction Therapeutics Revenue Market Share by P-002 2012-2017
  1.3.3 Global Alcohol Addiction Therapeutics Price by P-002 2012-2017
  1.3.4
  1.3.5
1.4 Alcohol Addiction Therapeutics, by 05253 2012-2017
  1.4.1 Global Alcohol Addiction Therapeutics Sales Market Share by 05253 2012-2017
  1.4.2 Global Alcohol Addiction Therapeutics Revenue Market Share by 05253 2012-2017
  1.4.3 Global Alcohol Addiction Therapeutics Price by 05253 2012-2017
  1.4.4
  1.4.5
1.5 Alcohol Addiction Therapeutics, by -436 2012-2017
  1.5.1 Global Alcohol Addiction Therapeutics Sales Market Share by -436 2012-2017
  1.5.2 Global Alcohol Addiction Therapeutics Revenue Market Share by -436 2012-2017
  1.5.3 Global Alcohol Addiction Therapeutics Price by -436 2012-2017
  1.5.4
  1.5.5
1.6 Alcohol Addiction Therapeutics, by -71441 2012-2017
  1.6.1 Global Alcohol Addiction Therapeutics Sales Market Share by -71441 2012-2017
  1.6.2 Global Alcohol Addiction Therapeutics Revenue Market Share by -71441 2012-2017
  1.6.3 Global Alcohol Addiction Therapeutics Price by -71441 2012-2017
  1.6.4
  1.6.5

CHAPTER TWO UNITED STATES ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW

2.1 United States Alcohol Addiction Therapeutics Market Sales Volume Revenue and Price 2012-2017
2.2 Alcohol Addiction Therapeutics, by 1212 2012-2017
  2.2.1 United States Alcohol Addiction Therapeutics Sales Market Share by 1212 2012-2017
  2.2.2 United States Alcohol Addiction Therapeutics Revenue Market Share by 1212 2012-2017
  2.2.3 United States Alcohol Addiction Therapeutics Price by 1212 2012-2017
  2.2.4
  2.2.5
2.3 Alcohol Addiction Therapeutics, by P-002 2012-2017
  2.3.1 United States Alcohol Addiction Therapeutics Sales Market Share by P-002 2012-2017
  2.3.2 United States Alcohol Addiction Therapeutics Revenue Market Share by P-002 2012-2017
  2.3.3 United States Alcohol Addiction Therapeutics Price by P-002 2012-2017
  2.3.4
  2.3.5
2.4 Alcohol Addiction Therapeutics, by 05253 2012-2017
  2.4.1 United States Alcohol Addiction Therapeutics Sales Market Share by 05253 2012-2017
  2.4.2 United States Alcohol Addiction Therapeutics Revenue Market Share by 05253 2012-2017
  2.4.3 United States Alcohol Addiction Therapeutics Price by 05253 2012-2017
  2.4.4
  2.4.5
2.5 Alcohol Addiction Therapeutics, by -436 2012-2017
  2.5.1 United States Alcohol Addiction Therapeutics Sales Market Share by -436 2012-2017
  2.5.2 United States Alcohol Addiction Therapeutics Revenue Market Share by -436 2012-2017
  2.5.3 United States Alcohol Addiction Therapeutics Price by -436 2012-2017
  2.5.4
  2.5.5
2.6 Alcohol Addiction Therapeutics, by -71441 2012-2017
  2.6.1 United States Alcohol Addiction Therapeutics Sales Market Share by -71441 2012-2017
  2.6.2 United States Alcohol Addiction Therapeutics Revenue Market Share by -71441 2012-2017
  2.6.3 United States Alcohol Addiction Therapeutics Price by -71441 2012-2017
  2.6.4
  2.6.5

CHAPTER THREE ALCOHOL ADDICTION THERAPEUTICS BY REGIONS 2012-2017

3.1 Global Alcohol Addiction Therapeutics Sales Market Share by Regions 2012-2017
3.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Regions 2012-2017
3.3 Global Alcohol Addiction Therapeutics Price by Regions 2012-2017
3.4 North America
  3.4.1 United States
    3.4.1.1 California
    3.4.1.2 Texas
    3.4.1.3 New York
    3.4.1.4 Others in United States
  3.4.2 Canada
3.5 Latin America
  3.5.1 Mexico
  3.5.2 Brazil
  3.5.3 Argentina
  3.5.4 Others in Latin America
3.6 Europe
  3.6.1 Germany
  3.6.2 United Kingdom
  3.6.3 France
  3.6.4 Italy
  3.6.5 Spain
  3.6.6 Russia
  3.6.7 Netherland
  3.6.8 Others in Europe
3.7 Asia & Pacific
  3.7.1 China
  3.7.2 Japan
  3.7.3 India
  3.7.4 Korea
  3.7.5 Australia
  3.7.6 Southeast Asia
    3.7.6.1 Indonesia
    3.7.6.2 Thailand
    3.7.6.3 Philippines
    3.7.6.4 Vietnam
    3.7.6.5 Singapore
    3.7.6.6 Malaysia
    3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
  3.8.1 South Africa
  3.8.2 Egypt
  3.8.3 Turkey
  3.8.4 Saudi Arabia
  3.8.5 Iran
  3.8.6 Others in Africa & Middle East

CHAPTER FOUR GLOBAL ALCOHOL ADDICTION THERAPEUTICS BY COMPANIES 2012-2017

4.1 Global Alcohol Addiction Therapeutics Sales Volume Market Share by Companies 2012-2017
4.2 Global Alcohol Addiction Therapeutics Revenue Share by Companies 2012-2017
4.3 Global Top Companies Alcohol Addiction Therapeutics Key Product Model and Market Performance
4.4 Global Top Companies Alcohol Addiction Therapeutics Key Target Consumers and Market Performance

CHAPTER FIVE UNITED STATES ALCOHOL ADDICTION THERAPEUTICS BY COMPANIES 2012-2017

5.1 United States Alcohol Addiction Therapeutics Sales Volume Market Share by Companies 2012-2017
5.2 United States Alcohol Addiction Therapeutics Revenue Share by Companies 2012-2017
5.3 United States Top Companies Alcohol Addiction Therapeutics Key Product Model and Market Performance
5.4 United States Top Companies Alcohol Addiction Therapeutics Key Target Consumers and Market Performance

CHAPTER SIX GLOBAL ALCOHOL ADDICTION THERAPEUTICS BY CONSUMER 2012-2017

6.1 Global Alcohol Addiction Therapeutics Sales Market Share by Consumer 2012-2017
6.2 Hospital
6.3 Clinic
6.4 Others
6.5 Consuming Habit and Preference

CHAPTER SEVEN GLOBAL ALCOHOL ADDICTION THERAPEUTICS BY CONSUMER 2012-2017

7.1 Global Alcohol Addiction Therapeutics Sales Market Share by Consumer 2012-2017
7.2 Hospital
7.3 Clinic
7.4 Others
7.5 Consuming Habit and Preference

CHAPTER EIGHT TOP COMPANIES PROFILE

8.1 AstraZeneca Plc
  8.1.1 AstraZeneca Plc Company Details and Competitors
  8.1.2 AstraZeneca Plc Key Alcohol Addiction Therapeutics Models and Performance
  8.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.2 BioCorRx Inc
  8.2.1 BioCorRx Inc Company Details and Competitors
  8.2.2 BioCorRx Inc Key Alcohol Addiction Therapeutics Models and Performance
  8.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.2.4 BioCorRx Inc Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.3 Bionex Pharmaceuticals LLC
  8.3.1 Bionex Pharmaceuticals LLC Company Details and Competitors
  8.3.2 Bionex Pharmaceuticals LLC Key Alcohol Addiction Therapeutics Models and Performance
  8.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.4 Cerecor Inc
  8.4.1 Cerecor Inc Company Details and Competitors
  8.4.2 Cerecor Inc Key Alcohol Addiction Therapeutics Models and Performance
  8.4.3 Cerecor Inc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.4.4 Cerecor Inc Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.5 Chronos Therapeutics Ltd
  8.5.1 Chronos Therapeutics Ltd Company Details and Competitors
  8.5.2 Chronos Therapeutics Ltd Key Alcohol Addiction Therapeutics Models and Performance
  8.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.5.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.6 Corcept Therapeutics Inc
  8.6.1 Corcept Therapeutics Inc Company Details and Competitors
  8.6.2 Corcept Therapeutics Inc Key Alcohol Addiction Therapeutics Models and Performance
  8.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.6.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.7 Curemark LLC
  8.7.1 Curemark LLC Company Details and Competitors
  8.7.2 Curemark LLC Key Alcohol Addiction Therapeutics Models and Performance
  8.7.3 Curemark LLC Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.7.4 Curemark LLC Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.8 Eli Lilly and Company
  8.8.1 Eli Lilly and Company Company Details and Competitors
  8.8.2 Eli Lilly and Company Key Alcohol Addiction Therapeutics Models and Performance
  8.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.8.4 Eli Lilly and Company Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.9 Ethypharm SA
  8.9.1 Ethypharm SA Company Details and Competitors
  8.9.2 Ethypharm SA Key Alcohol Addiction Therapeutics Models and Performance
  8.9.3 Ethypharm SA Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.9.4 Ethypharm SA Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.10 H. Lundbeck A/S
  8.10.1 H. Lundbeck A/S Company Details and Competitors
  8.10.2 H. Lundbeck A/S Key Alcohol Addiction Therapeutics Models and Performance
  8.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
  8.10.4 H. Lundbeck A/S Alcohol Addiction Therapeutics Sales Volume Revenue Price Cost and Gross Margin
8.11 Heptares Therapeutics Ltd
8.12 Indivior Plc
8.13 Kinnov Therapeutics SAS
8.14 Kyorin Pharmaceutical Co Ltd
8.15 Lohocla Research Corp
8.16 Montisera Ltd
8.17 Omeros Corp
8.18 Opiant Pharmaceuticals Inc

CHAPTER NINE INDUSTRY CHAIN AND SUPPLY CHAIN

9.1 Alcohol Addiction Therapeutics Industry Chain Structure
  9.1.1 R&D
  9.1.2 Raw Materials (Components)
  9.1.3 Manufacturing Plants
  9.1.4 Regional Trading (Import Export and Local Sales)
  9.1.5 Online Sales Channel
  9.1.6 Offline Channel
  9.1.7 End Users
9.2 Alcohol Addiction Therapeutics Manufacturing
  9.2.1 Key Components
  9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

CHAPTER TEN GLOBAL ALCOHOL ADDICTION THERAPEUTICS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

10.1 Global Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 1212 (2017-2022)
10.5 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by P-002 (2017-2022)
10.6 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 05253 (2017-2022)
10.7 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -436 (2017-2022)
10.8 Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -71441 (2017-2022)

CHAPTER ELEVEN UNITED STATES ALCOHOL ADDICTION THERAPEUTICS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 United States Alcohol Addiction Therapeutics Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 1212 (2017-2022)
11.5 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by P-002 (2017-2022)
11.6 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 05253 (2017-2022)
11.7 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -436 (2017-2022)
11.8 United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -71441 (2017-2022)

CHAPTER TWELVE DEVELOPMENT TREND AND RESEARCH CONCLUSION

12.1 Development Trend
12.2 Research Conclusion

CHAPTER THIRTEEN METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
LIST OF TABLES AND FIGURES

Table Global Alcohol Addiction Therapeutics Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by 1212 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Market Share by 1212 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by 1212 in 2016
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) by 1212 (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by 1212 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by 1212 in 2016
Table Global Alcohol Addiction Therapeutics Price (USD/Pcs) by 1212 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by P-002 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Market Share by P-002 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by P-002 in 2016
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) by P-002 (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by P-002 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by P-002 in 2016
Table Global Alcohol Addiction Therapeutics Price (USD/Pcs) by P-002 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by 05253 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Market Share by 05253 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by 05253 in 2016
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) by 05253 (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by 05253 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by 05253 in 2016
Table Global Alcohol Addiction Therapeutics Price (USD/Pcs) by 05253 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by -436 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Market Share by -436 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by -436 in 2016
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) by -436 (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by -436 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by -436 in 2016
Table Global Alcohol Addiction Therapeutics Price (USD/Pcs) by -436 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by -71441 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Market Share by -71441 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by -71441 in 2016
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) by -71441 (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by -71441 (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by -71441 in 2016
Table Global Alcohol Addiction Therapeutics Price (USD/Pcs) by -71441 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by 1212 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales Market Share by 1212 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by 1212 in 2016
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by 1212 (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue Market Share by 1212 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by 1212 in 2016
Table United States Alcohol Addiction Therapeutics Price (USD/Pcs) by 1212 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by P-002 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales Market Share by P-002 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by P-002 in 2016
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by P-002 (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue Market Share by P-002 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by P-002 in 2016
Table United States Alcohol Addiction Therapeutics Price (USD/Pcs) by P-002 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by 05253 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales Market Share by 05253 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by 05253 in 2016
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by 05253 (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue Market Share by 05253 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by 05253 in 2016
Table United States Alcohol Addiction Therapeutics Price (USD/Pcs) by 05253 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by -436 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales Market Share by -436 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by -436 in 2016
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by -436 (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue Market Share by -436 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by -436 in 2016
Table United States Alcohol Addiction Therapeutics Price (USD/Pcs) by -436 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by -71441 (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales Market Share by -71441 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by -71441 in 2016
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by -71441 (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue Market Share by -71441 (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by -71441 in 2016
Table United States Alcohol Addiction Therapeutics Price (USD/Pcs) by -71441 (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Share by Regions (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by Regions in 2016
Figure Global Alcohol Addiction Therapeutics Sales Market Share by Regions in 2017
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by Regions (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by Regions in 2016
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by Regions in 2017
Table Global Alcohol Addiction Therapeutics Price (USD/Pcs) by Regions (2012-2017)
Table North America Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table North America Alcohol Addiction Therapeutics Revenue (Million USD) by Regions (2012-2017)
Figure North America Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by Regions (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table Latin America Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table Latin America Alcohol Addiction Therapeutics Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table Europe Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table Europe Alcohol Addiction Therapeutics Revenue (Million USD) by Regions (2012-2017)
Figure Europe Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table Asia & Pacific Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table Asia & Pacific Alcohol Addiction Therapeutics Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table Africa & Middle East Alcohol Addiction Therapeutics Sales (K Pcs) by Regions (2012-2017)
Table Africa & Middle East Alcohol Addiction Therapeutics Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Volume (K Pcs) by Major Companies (2012-2017)
Table Global Alcohol Addiction Therapeutics Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share by Major Companies 2016
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share by Major Companies 2017
Table Global Alcohol Addiction Therapeutics Revenue (Million USD) by Major Companies (2012-2017)
Table Global Alcohol Addiction Therapeutics Revenue Market Share by Major Companies (2012-2017)
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by Major Companies 2016
Figure Global Alcohol Addiction Therapeutics Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Alcohol Addiction Therapeutics Sales Volume (K Pcs) by Top Companies (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share by Top Companies 2016
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share by Top Companies 2017
Table United States Alcohol Addiction Therapeutics Revenue (Million USD) by Top Companies (2012-2017)
Table United States Alcohol Addiction Therapeutics Revenue Market Share by Top Companies (2012-2017)
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by Top Companies 2016
Figure United States Alcohol Addiction Therapeutics Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) by Consumer (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by Consumer (2012-2017)
Figure Global Alcohol Addiction Therapeutics Sales Market Share by Consumer in 2016
Figure Global Hospital Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Clinic Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Others Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) by Consumer (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by Consumer (2012-2017)
Figure United States Alcohol Addiction Therapeutics Sales Market Share by Consumer in 2016
Figure United States Hospital Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Clinic Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Others Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
Table AstraZeneca Plc Company Details and Competitors
Table AstraZeneca Plc Key Alcohol Addiction Therapeutics Models and Performance
Table AstraZeneca Plc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table AstraZeneca Plc Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure AstraZeneca Plc Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure AstraZeneca Plc Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure AstraZeneca Plc Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure AstraZeneca Plc Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table BioCorRx Inc Company Details and Competitors
Table BioCorRx Inc Key Alcohol Addiction Therapeutics Models and Performance
Table BioCorRx Inc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table BioCorRx Inc Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure BioCorRx Inc Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure BioCorRx Inc Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure BioCorRx Inc Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure BioCorRx Inc Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Bionex Pharmaceuticals LLC Company Details and Competitors
Table Bionex Pharmaceuticals LLC Key Alcohol Addiction Therapeutics Models and Performance
Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Cerecor Inc Company Details and Competitors
Table Cerecor Inc Key Alcohol Addiction Therapeutics Models and Performance
Table Cerecor Inc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Cerecor Inc Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Cerecor Inc Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Cerecor Inc Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Cerecor Inc Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Cerecor Inc Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Chronos Therapeutics Ltd Company Details and Competitors
Table Chronos Therapeutics Ltd Key Alcohol Addiction Therapeutics Models and Performance
Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Corcept Therapeutics Inc Company Details and Competitors
Table Corcept Therapeutics Inc Key Alcohol Addiction Therapeutics Models and Performance
Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Corcept Therapeutics Inc Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Corcept Therapeutics Inc Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Curemark LLC Company Details and Competitors
Table Curemark LLC Key Alcohol Addiction Therapeutics Models and Performance
Table Curemark LLC Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Curemark LLC Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Curemark LLC Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Curemark LLC Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Curemark LLC Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Curemark LLC Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Eli Lilly and Company Company Details and Competitors
Table Eli Lilly and Company Key Alcohol Addiction Therapeutics Models and Performance
Table Eli Lilly and Company Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Eli Lilly and Company Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Eli Lilly and Company Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Eli Lilly and Company Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Eli Lilly and Company Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Eli Lilly and Company Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Ethypharm SA Company Details and Competitors
Table Ethypharm SA Key Alcohol Addiction Therapeutics Models and Performance
Table Ethypharm SA Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table Ethypharm SA Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Ethypharm SA Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Ethypharm SA Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure Ethypharm SA Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Ethypharm SA Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table H. Lundbeck A/S Company Details and Competitors
Table H. Lundbeck A/S Key Alcohol Addiction Therapeutics Models and Performance
Table H. Lundbeck A/S Alcohol Addiction Therapeutics Business SWOT Analysis and Forecast
Table H. Lundbeck A/S Alcohol Addiction Therapeutics Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure H. Lundbeck A/S Alcohol Addiction Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure H. Lundbeck A/S Alcohol Addiction Therapeutics Sales Market Share (%) in Global (2012-2017)
Figure H. Lundbeck A/S Alcohol Addiction Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure H. Lundbeck A/S Alcohol Addiction Therapeutics Revenue Market Share (%) in Global (2012-2017)
Table Heptares Therapeutics Ltd Company Details and Competitors
Table Indivior Plc Company Details and Competitors
Table Kinnov Therapeutics SAS Company Details and Competitors
Table Kyorin Pharmaceutical Co Ltd Company Details and Competitors
Table Lohocla Research Corp Company Details and Competitors
Table Montisera Ltd Company Details and Competitors
Table Omeros Corp Company Details and Competitors
Table Opiant Pharmaceuticals Inc Company Details and Competitors
Figure Global Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Alcohol Addiction Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global Alcohol Addiction Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Share Forecast by Regions in 2022
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by Application in 2022
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 1212 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 1212 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by 1212 in 2022
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by P-002 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by P-002 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by P-002 in 2022
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 05253 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 05253 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by 05253 in 2022
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -436 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -436 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by -436 in 2022
Table Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -71441 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -71441 (2017-2022)
Figure Global Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by -71441 in 2022
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure United States Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Alcohol Addiction Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Regions (2017-2022)
Table United States Alcohol Addiction Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Share Forecast by Regions in 2022
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by Application (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by Application in 2022
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 1212 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 1212 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by 1212 in 2022
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by P-002 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by P-002 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by P-002 in 2022
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 05253 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by 05253 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by 05253 in 2022
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -436 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -436 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by -436 in 2022
Table United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -71441 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales (K Pcs) Forecast by -71441 (2017-2022)
Figure United States Alcohol Addiction Therapeutics Sales Volume Market Share Forecast by -71441 in 2022


More Publications